Nura Bio
Clinical-stage biopharmaceutical company developing neuroprotective small molecule therapies.
Biotechnology
📍 South San Francisco, CA
Current Valuation
Private
PRIVATE
Clinical-stage biopharmaceutical company developing neuroprotective small molecule therapies. Headquartered in South San Francisco, CA. Raised $73.8M in Series B funding in June 2026 led by The Column Group.
Company Profile
HQ
South San Francisco, CA
Last Round
Series B — $74M (Jun 2026) · Lead: The Column Group
Fundraising Status
Series B · $74M · this month
privateTotal raised $74M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $74M | Jun 2026 | The Column Group | — |
Investors
The Column Group · Euclidean Capital · Samsara BioCapital · Sanofi Ventures
BiotechnologyBiopharmaceuticalsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.